Aspen Pharmacare has offered to acquire GlaxoSmithKline's thrombosis drugs Arixtra and Fraxiparine and a related manufacturing site in France. Financial terms of the proposed deal were not disclosed. GSK said the move would be in line with its goal of emphasizing high growth potential.

Full Story:

Related Summaries